Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
01/2008
01/02/2008CN100358888C Novel guanidine mimics as factor Xa inhibitors
01/02/2008CN100358874C 3,4-dihydroquinazoline derivatives as t-type calcium channel blockers and method of preparing the same
01/02/2008CN100358870C Aminotetralin derivatives as muscarinic receptor antagonists
01/01/2008USRE39991 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
01/01/2008US7314950 Sulfinating a trans-alkyl 4-aminocyclohexanecarboxylate (formed by iminating the cis-analog with a benzaldehyde and hydrolyzing the product) with an alkanesulfinyl chloride and oxidizing the product to form an alkyl 4-alkylsulfonamidocyclohexanecarboxylate, which then may be hydrolyzed
01/01/2008US7314938 Immune and/or inflammatory disorders; autoimmune disorders; disorders mediated by the CD11/CD18 family of cellular adhesion molecules (e.g., LFA-1); antagonize CD11/CD18 receptors associated with leukocytes.
01/01/2008US7314937 Non-imidazole aryl alkylamines compounds as histamine H3 receptor antagonists, preparation and therapeutic uses
01/01/2008US7314933 Vanilloid receptor ligands and their use in treatments
01/01/2008US7314888 2-{5-[(2,4-diisobutoxyphenyl)(hydroxy)methyl]-2-isobutoxyphenyl}-acetic acid; inhibits the activity of transcription factor AP-1
01/01/2008US7314884 non-insulin dependent diabetes mellitus, and impaired glucose tolerance; dipeptidyl peptidase IV (DPP-IV) inhibitors eg (2S)-1-{[(1S)-2-(5-cyano-2-methyl-indol-1-yl)-1-methyl-ethylamino]-acetyl}-pyrrolidine-2-carbonitrile
01/01/2008US7314883 (+-)-3-(1H-Indazol-5-yl)-2-{[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidine-1-carbonyl]-amino}-propionic acid to treat neurogenic vasodilation, neurogenic inflammaton, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases
01/01/2008US7314879 N-Acylpiperazine derivatives for obesity, diabetes, and erectile dysfunction treatment; sexual disorders
01/01/2008US7314876 Administering to mammals nitrogen compounds, as mitogen activated kinase inhibitors, for prophylaxis asthma, respiratory system disorders, graft versus host disease, atherosclerosis and arthritis
01/01/2008US7314874 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide;modified amidine elements of high potency in vitro, excellent pharmacological and pharmaceutical properties in vivo
01/01/2008US7314849 6-(poly-substituted aryl)-4-aminopicolinates and their use as herbicides
12/2007
12/27/2007WO2007150010A2 Cyclopropyl amine derivatives as histamin h3 receptor modulators
12/27/2007WO2007149478A2 Pyrazine derivatives with extended conjugation and uses thereof
12/27/2007WO2007149033A1 Substituted isoindoles as bace inhibitors and their use
12/27/2007WO2007149031A1 Isoquinoline derivatives and their use as inhibitors of cytokine mediated diseases
12/27/2007WO2007148835A1 Agent for overcoming resistance to anti-cancer agent
12/27/2007WO2007148780A1 6-(heterocycle-substituted benzyl)-4-oxoquinoline compound and use of the same as hiv integrase inhibitor
12/27/2007WO2007148774A1 Cyclic amine compound
12/27/2007WO2007148738A1 Pest control agent containing novel pyridyl-methanamine derivative or salt thereof
12/27/2007WO2007148676A1 Therapeutic or prophylactic agent for leukemia
12/27/2007WO2007148648A1 Therapeutic or prophylactic agent for multiple sclerosis
12/27/2007WO2007148185A2 Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors
12/27/2007WO2007147874A1 Pyridine and pyrazine derivatives as mnk kinase inhibitors
12/27/2007WO2007147746A1 2-pyrazinecarboxamide derivatives
12/27/2007WO2007130821A3 Mglur5 modulators ii
12/27/2007WO2007117559A8 Renin inhibitors
12/27/2007WO2007116230A8 Azetidine derivatives as g-protein coupled receptor (gpr119 ) agonists
12/27/2007WO2007115077A3 Bicyclic benzimidazole compounds and their use as metabotropic glutamate receptor potentiators
12/27/2007WO2007112093A3 Benzimidazolyl-pyridine compounds for inflammation and immune-related uses
12/27/2007WO2007092435A3 11-beta hsd1 inhibitors
12/27/2007WO2006131491A8 Polymorphs of ethyl 3-[(2-{[4-(hexyloxycarbonylamino-iminomethyl)phenylamino]methyl}-1-methyl-1h-benzimidazole-5-carbonyl)pyridin-2-ylamino]propionate
12/27/2007WO2006129181A3 Preparation of 4-pyrimidone derivatives for treating inflammatory diseases
12/27/2007US20070299112 Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i
12/27/2007US20070299110 Novel Tetrazole Derivatives as Positive Allosteric Modulators of Metabotropic Glutamate
12/27/2007US20070299109 Dimeric Compounds Of Piperidine, Piperazine Or Morpholine Or Their 7-Membered Analogs Suitable For The Treatment Of Neurodegenerative Disorders
12/27/2007US20070299108 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
12/27/2007US20070299105 2-Cyanopropanoic Acid Amide and Ester Derivatives and Methods of Their Use
12/27/2007US20070299102 Diphenyl Ox-Indol-2-One Compounds and Their Use in the Treatment of Cancer
12/27/2007US20070299092 Quinone Substituted Quinazoline and Quinoline Kinase Inhibitors
12/27/2007US20070299083 6-Methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline hydrochloric acid salts
12/27/2007US20070299082 (+-)-3-(6-Phenylethynyl-pyridazin-3-yloxy)-1-aza-bicyclo[2.2.2]octane; (+-)-N-{4-[6-(1-Aza-bicyclo[2.2.2]oct-3-yloxy)-pyridazin-3-ylethynyl]-phenyl}-acetamide; nicotinic and monoamine receptor modulators
12/27/2007US20070299081 Heterocyclic Derivatives and Their Use as Mediators of Stearoyl-Coa Desaturase
12/27/2007US20070299076 Substituted 3-Amino-Pyrrolidino-4-Lactams
12/27/2007US20070299073 Imidazolyl derivatives
12/27/2007US20070299070 Such as 5-(benzyloxy)-N-[4-(morpholinomethyl)phenyl]-1H-indole-2-carboxamide and 5-(benzyloxy)-N-[4-(morpholinomethyl)phenyl]-1H-benzimidazole-2-carboxamide; melanin-concentrating hormone receptor antagonist, useful for treating obesity
12/27/2007US20070299069 Methods for treating hepatitis C
12/27/2007US20070299068 viricides comprising (3-cyano-indol-2-yl)phenyl derivatives, used for for treating viral diseases and infections or for affecting viral internal ribosome entry site (IRES) activity
12/27/2007US20070299063 N3 alkylated benzimidazole derivatives as mek inhibitors
12/27/2007US20070299060 (1R,2R,3S,4S)-5-fluoro-N4-[3- methylaminocarbonylbicyclo[2.2.1]hept-5- en-2-yl)-N2-[1-methylsulfonyl-2,3- dihydroindol-5-yl]-2,4-pyrimidinediamine, used to inhibit cellular proliferation and to treat proliferate diseases such as tumorigenic cancers
12/27/2007US20070299059 Compostions and methods relating to novel compounds and targets thereof
12/27/2007US20070299058 Anxiolytic Agents With Reduced Sedative And Ataxic Effects
12/27/2007US20070299057 Heterocyclic piperidines as modulators of chemokine receptor activity
12/27/2007US20070299056 Benzazepine derivatives for the treatment of neurological disorders
12/27/2007US20070299039 Substituted benz-azoles and methods of their use as inhibitors of Raf kinase
12/27/2007DE102006028649A1 New 5-quinoline derivatives are topoisomerase inhibitors useful to treat bacterial infections
12/27/2007CA2656625A1 Substituted isoindoles as bace inhibitors and their use
12/27/2007CA2655895A1 Agent for overcoming resistance to anti-cancer agent
12/27/2007CA2655857A1 Pyrazine derivatives with extended conjugation and uses thereof
12/27/2007CA2655801A1 Therapeutic or prophylactic agent for leukemia
12/27/2007CA2655604A1 Cyclopropyl amine derivatives
12/27/2007CA2655573A1 Therapeutic or prophylactic agent for multiple sclerosis
12/27/2007CA2654781A1 2-pyrazinecarboxamide derivatives
12/27/2007CA2654358A1 Pyridine and pyrazine derivatives as mnk kinase inhibitors
12/26/2007EP1870414A1 Thienopyridine derivative, or quinoline derivative, or quinazoline derivative, having c-met autophosphorylation inhibiting potency
12/26/2007EP1870402A1 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors
12/26/2007EP1870399A1 Hydroxamate derivatives useful as deacetylase inhibitors
12/26/2007EP1870100A1 Pharmaceutical composition for oral application comprising ethyl 3-(2-(4-(hexyloxycarbonylamidino)phenylaminomethyl)-1-methyl-1H-benzimidazole-5-carbonyl)-2-pyridylamino)propionate mesylate
12/26/2007EP1870099A1 Protective agent for retinal neuronal cell comprising indazole derivative as active ingredient
12/26/2007EP1869052A1 Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors
12/26/2007EP1869019A1 Bicyclic [3.1.0] heteroaryl amides as type i glycine transport inhibitors
12/26/2007EP1869017A1 3- (1,2,4-triazol-3ylalkyl) azabriclo (3.1.0) hexane derivatives as modulators of dopamine d3 receptors
12/26/2007EP1869016A1 Imidazolo-5-yl-2-anilo-pyrimidines as agents for the inhibition of cell proliferation
12/26/2007EP1869015A1 An improved process for the manufacture of rabeprazole sodium
12/26/2007EP1869014A2 Pyrimidine derivatives
12/26/2007EP1869013A1 Substituted chroman derivatives, method for the production and the use thereof in the form of antiphlogistics
12/26/2007EP1869012A1 Substituted benzylimidazoles useful for the treatment of inflammatory diseases
12/26/2007EP1869011A2 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors
12/26/2007EP1869010A1 3-sulfonylamino-pyrrolidine-2-one derivatives as factor xa inhibitors
12/26/2007EP1869006A1 Pyrimidindione derivatives as prokineticin 2 receptor antagonists
12/26/2007EP1869003A1 Indazoles as glucocorticoid receptor ligands
12/26/2007EP1869002A1 Substituted indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their preparation and use in medicaments
12/26/2007EP1869000A1 Cyclopentapyridine and tetrahydroquinoline derivatives
12/26/2007EP1868997A1 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them
12/26/2007EP1868994A1 Sulfonylpyrroles as histone deacetylase inhibitors
12/26/2007EP1868991A1 Histamine h3 receptor agents, preparation and therapeutic uses
12/26/2007EP1868607A2 Isoqunoline compounds and methods of use thereof
12/26/2007EP1868605A2 Phenyl and pyridyl lta4h modulators
12/26/2007EP1868435A2 Combinations, methods and compositions for treating cancer
12/26/2007EP1751138B1 Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders
12/26/2007EP1556390A4 Functionalized ionic liquids, and methods of use thereof
12/26/2007EP1539708B1 Benzimidazolones and their use as cytokine inhibitors
12/26/2007EP1233769B1 Imidazole derivatives
12/26/2007EP1187835B1 Optically active quinoline carboxylic acid derivatives having 7-pyrrolidine substitutes causing optical activity and a process for preparing thereof
12/26/2007CN101094854A Constrained compounds as cgrp-receptor antagonists
12/26/2007CN101094848A Organic compounds
12/26/2007CN101094847A Aryloxy-substituted benzimidazole derivatives
1 ... 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 ... 1080